All In Biotech

Drug Trial Radar · NCT02100748

A Study of TRV130 for the Treatment of Pain After Bunionectomy

A Phase 2, Multicenter, Randomized, Double-blind, Multiple-dose, Adaptive, Placebo- and Active-controlled Study of TRV130 for the Treatment of Acute Postoperative Pain After Bunionectomy

Last checked: Nov 20, 2026Latest source record: Sep 16, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 333 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

333

Actual

Start

Apr 2014

Primary completion

Oct 2014

Study completion Oct 2014

Sponsor

Lead sponsor
Trevena Inc.Industry
Sponsor type
Industry
First posted
Apr 1, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective is to evaluate the analgesic efficacy of IV TRV130 compared with placebo in patients with acute postoperative pain after bunionectomy.

Conditions

  • Acute Pain

Interventions

  • TRV130Drug

    TRV130 1 - 4 mg will be administered every 4 hours

  • MorphineDrug

    Morphine 4 mg will be administered every 4 hours

  • PlaceboDrug

    Placebo will be administered every 4 hours

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time Weighted Average (TWA) Change From Baseline in Pain Score Over 48 Hours Between TRV130 and PlaceboTime frame: 48 hours

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Premier Research

    Phoenix, Arizona

  • Chesapeake Research Group

    Pasadena, Maryland

  • Premier Research

    Austin, Texas

  • Jean Brown Research

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.